FOSCAVIR

This brand name is authorized in United States. It is also authorized in Estonia, France, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Singapore, Spain, UK.

Active ingredients

The drug FOSCAVIR contains one active pharmaceutical ingredient (API):

1	Foscarnet UNII 964YS0OOG1 - FOSCARNET SODIUM
	Foscarnet is an antiviral agent with a broad spectrum inhibiting all known human viruses of the herpes group. Foscarnet exerts its antiviral activity by a direct inhibition of viral specific DNA polymerase a reverse transcriptase at concentrations that do not affect cellular DNA polymerases.
	Read more about Foscarnet

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FOSCAVIR Solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J05AD01	Foscarnet	J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AD Phosphonic acid derivatives
Discover more medicines within J05AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1179738, 1240456, 1409161, 1584334, 1769531
ES	Centro de información online de medicamentos de la AEMPS	59712
FR	Base de données publique des médicaments	62686823
GB	Medicines & Healthcare Products Regulatory Agency	45964
IL	מִשְׂרַד הַבְּרִיאוּת	6786
JP	医薬品医療機器総合機構	6250403A1033
LT	Valstybinė vaistų kontrolės tarnyba	1090648
MT	Medicines Authority	AA565/44201, AA729/22902
NL	Z-Index G-Standaard	13611577
NL	Z-Index G-Standaard, PRK	33081
NZ	Medicines and Medical Devices Safety Authority	5486
SG	Health Sciences Authority	08260P
US	FDA, National Drug Code	76310-024